Detalhe da pesquisa
1.
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus highdose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2-3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study.
Lancet
; 2024 Jun 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38851203
2.
Vimseltinib versus placebo for tenosynovial giant cell tumour (MOTION): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 2024 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38843860
3.
Plexiform Fibromyxoma in the Stomach: Immunohistochemical Profile and Comprehensive Genetic Characterization.
Int J Mol Sci
; 25(9)2024 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38732067
4.
The Complex Management of the Breast Angiosarcoma: A Retrospective Study.
Oncology
; 101(4): 234-239, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36538913
5.
A comparison of simplified protocols of personalized dosimetry in NEN patients treated by radioligand therapy (RLT) with [177Lu]Lu-DOTATATE to favor its use in clinical practice.
Eur J Nucl Med Mol Imaging
; 50(6): 1753-1764, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36688980
6.
Identification of functional pathways and molecular signatures in neuroendocrine neoplasms by multi-omics analysis.
J Transl Med
; 20(1): 306, 2022 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35794609
7.
Streptozotocin, 1982-2022: Forty Years from the FDA's Approval to Treat Pancreatic Neuroendocrine Tumors.
Neuroendocrinology
; 112(12): 1155-1167, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35537416
8.
Is immunotherapy in the future of therapeutic management of sarcomas?
J Transl Med
; 19(1): 173, 2021 04 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33902630
9.
The Role of lncRNAs in Rare Tumors with a Focus on HOX Transcript Antisense RNA (HOTAIR).
Int J Mol Sci
; 22(18)2021 Sep 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34576322
10.
Aberrant Expression of Long Non Coding RNA HOTAIR and De-Regulation of the Paralogous 13 HOX Genes Are Strongly Associated with Aggressive Behavior of Gastro-Entero-Pancreatic Neuroendocrine Tumors.
Int J Mol Sci
; 22(13)2021 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34208964
11.
Morphological Factors Related to Nodal Metastases in Neuroendocrine Tumors of the Appendix: A Multicentric Retrospective Study.
Ann Surg
; 271(3): 527-533, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29995678
12.
Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues.
Gastroenterology
; 155(2): 479-489.e7, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29655834
13.
Cetuximab, irinotecan and fluorouracile in fiRst-line treatment of immunologically-selected advanced colorectal cancer patients: the CIFRA study protocol.
BMC Cancer
; 19(1): 899, 2019 Sep 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31500586
14.
Prognostic impact of tumour burden in stage IV neuroendocrine neoplasia: A comparison between pancreatic and gastrointestinal localizations.
Pancreatology
; 19(8): 1067-1073, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31587962
15.
Novel nanohydrogel of hyaluronic acid loaded with quercetin alone and in combination with temozolomide as new therapeutic tool, CD44 targeted based, of glioblastoma multiforme.
J Cell Physiol
; 233(10): 6550-6564, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29030990
16.
Gemcitabine mono-therapy versus gemcitabine plus targeted therapy in advanced pancreatic cancer: a meta-analysis of randomized phase III trials.
Acta Oncol
; 56(3): 377-383, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28256961
17.
Diabetes and Body Mass Index Are Associated with Neuropathy and Prognosis in Colon Cancer Patients Treated with Capecitabine and Oxaliplatin Adjuvant Chemotherapy.
Oncology
; 90(1): 36-42, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26731722
18.
Sequencing Treatments in Patients with Advanced Well-Differentiated Pancreatic Neuroendocrine Tumor (pNET): Results from a Large Multicenter Italian Cohort.
J Clin Med
; 13(7)2024 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38610840
19.
Metabolomic profile of neuroendocrine tumors identifies methionine, porphyrin, and tryptophan metabolisms as key dysregulated pathways associated with patient survival.
Eur J Endocrinol
; 190(1): 62-74, 2024 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38033321
20.
The Management of Phaeochromocytomas and Paragangliomas in the Era of Precision Medicine: Where Are We Now? Evidence-Based Systemic Treatment Options and Future Cluster Oriented Perspectives.
Pharmaceuticals (Basel)
; 17(3)2024 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38543140